naproxen has been researched along with Thromboembolism in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lanes, S; Singh, G; Triadafilopoulos, G | 1 |
| Burnier, M; Mathieu, C; Meier, P; Meyer zu Starten, A | 1 |
| Curfman, GD; Drazen, JM; Morrissey, S | 1 |
| Auger, D; Grange, P; Hecquet, JP; Remond, A; Titon, JP; Ulliac, P; Vaissié, JJ | 1 |
| Cai, B; Guess, HA; Rhodes, T; Watson, DJ | 1 |
1 review(s) available for naproxen and Thromboembolism
| Article | Year |
|---|---|
[Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Naproxen; Pyrazoles; Risk Assessment; Sulfonamides; Thromboembolism | 2005 |
2 trial(s) available for naproxen and Thromboembolism
| Article | Year |
|---|---|
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular System; Diclofenac; Dose-Response Relationship, Drug; Europe; Female; Gastrointestinal Diseases; Humans; Male; Meloxicam; Middle Aged; Naproxen; North America; Piroxicam; Risk Factors; Severity of Illness Index; Thiazines; Thiazoles; Thromboembolism; Time Factors; Treatment Failure; Upper Gastrointestinal Tract | 2004 |
[Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent].
Topics: Adult; Aged; Ambulatory Care; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nadroparin; Naproxen; Prospective Studies; Risk Factors; Thromboembolism; Thrombophlebitis; Time Factors; Ultrasonography | 1994 |
2 other study(ies) available for naproxen and Thromboembolism
| Article | Year |
|---|---|
Expression of concern reaffirmed.
Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Research Design; Sulfones; Thromboembolism | 2006 |
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Case-Control Studies; England; Humans; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Regression Analysis; Risk; Survival Analysis; Thromboembolism; Wales | 2002 |